Italian Pharmaceutical Packaging Manufacturers (2026)

Italy is one of the world’s leading hubs for pharmaceutical packaging machinery, with companies clustered around Bologna and Emilia-Romagna producing blister packers, vial fillers, cartoners, and complete serialization lines. The sector forms a specialized segment within Italy’s EUR 10.2 billion packaging machinery industry, and its top firms export to over 100 countries. Yet most of these manufacturers still rely on a handful of trade fairs and agent networks to fill their sales pipeline.

Italy’s Pharmaceutical Packaging Cluster

The Emilia-Romagna region, often called “Packaging Valley,” is the global epicenter of pharmaceutical packaging machinery. Within a 100-kilometer radius of Bologna, dozens of specialized manufacturers design and build the automated lines that package tablets, capsules, injectables, and biologics for the world’s largest pharma companies.

Italy’s broader packaging machinery sector posted EUR 10.2 billion in turnover in 2025, up 2.1% year over year, with exports of EUR 8.1 billion accounting for nearly 80% of revenues. The pharmaceutical segment is one of the strongest verticals within this total, driven by global demand for compliance-ready packaging, biologics handling, and serialization technology.

The global pharmaceutical packaging market itself was valued at approximately USD 155 to 166 billion in 2025, with projections reaching USD 200 billion or more by the early 2030s. Italian manufacturers sit at the high end of this supply chain, providing the precision machinery that fills, seals, labels, and tracks every unit.

Leading Italian Pharmaceutical Packaging Manufacturers

Several world-class companies anchor Italy’s pharma packaging cluster:

Marchesini Group (Pianoro, Bologna) is one of the world’s largest manufacturers of packaging machines and lines dedicated to pharmaceuticals and cosmetics. Founded in 1974, the company reached a consolidated turnover exceeding EUR 500 million in recent years, with 87% of revenue from exports across 116 countries. Marchesini employs over 2,500 people and operates through 16 foreign subsidiaries and 35 agencies worldwide. Its product range covers blister machines, cartoners, end-of-line systems, and complete turnkey lines.

IMA Group (Bologna) is a multinational giant with consolidated revenues of approximately EUR 1.5 billion and 54 manufacturing facilities globally. IMA’s pharmaceutical division, IMA Pharma, encompasses specialized brands including IMA Active (solid dose), IMA Life (aseptic processing and freeze drying), IMA Safe (secondary packaging), and BFB (end-of-line solutions). The group exports roughly 84% of its output.

Romaco operates multiple Italian facilities in the Bologna area, including Macofar (liquid filling and sterile powder dosing) and Promatic (cartoning machines, track-and-trace systems, and case packers). Romaco serves pharmaceutical companies with manufacturing facilities across South America, India, and Eastern Europe.

CAM (Automatic Packaging Machines), founded in 1949, was the first Italian designer of automatic cartoning machines. Today CAM’s network spans 15 manufacturing companies, 17 trade centers with agents in 27 countries, and 14 after-sales centers serving pharmaceutical, cosmetic, and food clients.

Other notable players include MG2 (capsule fillers), Cama Group (secondary packaging), Neri (labeling and serialization, now part of Marchesini), and Stevanato Group (glass primary packaging), forming a deep and competitive supply chain.

Company	Headquarters	Specialization	Export Share
Marchesini Group	Pianoro, Bologna	Complete pharma packaging lines	87%
IMA Group	Bologna	Processing, filling, packaging	~84%
Romaco	Bologna (Italian ops)	Filling, cartoning, track-and-trace	Global
CAM	Bologna	Cartoning, complete lines	27 countries

Why Pharma Packaging Is Growing

Three forces are driving sustained demand for Italian pharmaceutical packaging technology:

Biologics and biosimilars require cold chain handling, aseptic filling, and specialized primary packaging that standard machinery cannot deliver. Italian manufacturers have invested heavily in cleanroom-compatible systems and lyophilization (freeze-drying) lines to serve this growing segment.

Serialization and track-and-trace mandates continue expanding globally. The EU’s Falsified Medicines Directive (FMD) requires 2D DataMatrix codes on every prescription pack, with Italy entering a two-year stabilization period in February 2025 before full compliance becomes mandatory in February 2027. Similar regulations in the US (DSCSA), Brazil, Russia, and across Asia mean pharma companies worldwide need machinery upgrades to meet traceability requirements.

Italy’s pharmaceutical industry is booming as a customer base too. Italian pharmaceutical exports reached approximately EUR 49 billion in 2023, with the sector achieving 150% growth over the past decade. Italy is now the world’s sixth-largest medicine exporter and the third-largest exporter of packaged drugs after Germany and Switzerland. This domestic strength creates a natural testing ground for Italian packaging machinery before it ships abroad.

The Dying Channels: How Pharma Packaging Makers Still Find Buyers

Despite their global reach, most Italian pharmaceutical packaging manufacturers generate pipeline through a narrow set of traditional channels.

Trade Fairs: Expensive, Seasonal, and Crowded

Pharmintech (Bologna/Milan), CPhI Worldwide, ACHEMA (Frankfurt), and interpack (Dusseldorf) are the marquee events. Pharmintech 2025 featured over 300 exhibitors from 24 countries and attracted more than 8,700 specialized visitors, up 37% from the previous edition.

But the economics are punishing. A mid-sized Italian pharma packaging company attending 4 to 6 international fairs per year spends EUR 80,000 to EUR 200,000 on booth space, machine transport, staffing, travel, and accommodation. The cost per qualified lead at pharmaceutical trade fairs runs $300 to $900+. And all of that activity concentrates into perhaps 15 to 20 selling days per year. That leaves 345 days with no proactive outreach to new buyers.

OEM and Pharma Company Dependency

Many smaller Italian packaging machinery firms depend heavily on a few large OEM relationships or direct contracts with multinational pharma companies. When a major customer delays a project or shifts suppliers, revenue drops sharply. Diversifying the customer base is critical, but sales teams at these firms typically number 3 to 5 people covering the entire world.

Agent Networks: One Region at a Time

The traditional Italian export model relies on agenti di commercio covering one or two markets each. For a pharma packaging company targeting the EU, North America, Middle East, India, Southeast Asia, and Latin America simultaneously, this means managing 6 to 10 independent agents with varying commission structures and inconsistent reporting. Coordination becomes a full-time job that most lean Italian manufacturers cannot staff.

Field Sales: High Cost, Limited Scale

A technical sales engineer in Italy costs EUR 45,000 to EUR 60,000+ per year in salary alone. Add travel to pharmaceutical plants in the US, India, and Brazil, and the fully loaded cost per rep exceeds EUR 80,000 annually. Each rep covers one or two regions at best. The cost per qualified lead from field sales runs $500 to $1,200+, and scaling means adding headcount linearly.

The 345-Day Problem

The core issue is structural. Italian pharmaceutical packaging manufacturers build machines that run 24/7 in cleanrooms across 100+ countries. But their sales process operates 15 to 20 days per year at trade fairs, supplemented by sporadic agent activity and inbound inquiries.

Research from 6sense’s 2025 Buyer Experience Report found that 95% of B2B buyers purchase from a vendor already on their initial shortlist. Buyers evaluate an average of 5 vendors and fill 4 shortlist spots on Day One, before ever contacting a seller. They do not reach out until roughly 61% through their buying journey.

For a pharma packaging manufacturer whose only touchpoints are Pharmintech and CPhI, this means the shortlist may already be locked before the fair opens.

Filling the Gap with AI-Powered Outbound

The solution is not to abandon Pharmintech or ACHEMA. These events still matter for machine demonstrations, regulatory discussions, and relationship building. The solution is to complement fairs with year-round, AI-powered prospecting that identifies and engages buyers across every target market simultaneously.

Signal-Based Targeting for Pharma Packaging

AI systems can identify pharmaceutical companies and contract manufacturers actively investing in new packaging capacity:

• New facility announcements from pharma companies expanding production
• Regulatory filings signaling product launches that require new packaging lines
• Serialization compliance deadlines in markets transitioning to track-and-trace mandates
• Capital expenditure disclosures from publicly traded pharma companies
• Job postings for packaging engineers and production managers at target companies

These signals reveal which companies will need blister packers, cartoners, or fill-finish lines in the next 6 to 18 months.

Precision Outreach at Scale

Once targets are identified, hyper-personalized email sequences reach packaging directors, procurement managers, and plant engineers directly. Messages reference the prospect’s specific product types (solid dose, injectables, biologics), relevant regulatory requirements (EU FMD, US DSCSA), and the manufacturer’s track record with comparable installations.

A well-built outbound engine reaches 500 to 1,000 targeted prospects per month across multiple markets simultaneously.

The Cost Comparison

Channel	Active Days/Year	Prospects Reached/Month	Cost per Qualified Lead
Trade fairs (4-6 events)	15-20 days	30-80 per fair	$300-$900+
Field sales rep (1 hire)	~220 days	15-30	$500-$1,200+
AI outbound engine	365 days	500-1,000	$150-$300

The difference compounds over time. Fairs and reps scale linearly: more events and more hires cost proportionally more. AI outbound improves with each iteration as targeting, messaging, and timing refine automatically.

Multilingual, Multi-Market Coverage

Italian pharma packaging exports reach buyers in the US, Germany, India, Brazil, the Middle East, and Southeast Asia. An AI outbound engine can generate sequences in English, German, French, Spanish, Portuguese, Arabic, and Hindi, reaching procurement teams in their native language. No single export manager or agent network can replicate that breadth.

What This Looks Like in Practice

Consider a mid-sized Italian pharma packaging manufacturer based near Bologna. They build blister lines and cartoning systems, exporting to 40+ countries. Their current sales process:

1. Attend Pharmintech, CPhI, and ACHEMA each year (EUR 150,000 total)
2. Maintain agents in Germany, the US, and India (8-12% commission each)
3. Collect 150 to 250 contacts across all events
4. Export manager follows up manually over 3 to 4 months
5. Close 3 to 5 new machine orders per year from fair leads

With an AI outbound engine running alongside:

1. Month 1: Identify 1,500 pharmaceutical manufacturers and CMOs across target markets showing expansion signals
2. Month 2: Launch personalized sequences to packaging and operations decision-makers at 600 companies
3. Month 3: First qualified replies convert to technical discussions and quote requests
4. Ongoing: 40 to 60 new qualified conversations per month, every month

The fairs still happen. But the pipeline never goes dark between events. And when you meet someone at CPhI, your CRM already has context because your outbound engine has been warming that market for months.

For more on how Italian manufacturers across sectors are adapting their export strategies, see our analysis of Italian pharmaceutical exporters and Italian machinery exporters.

Frequently Asked Questions

Which Italian companies are the biggest pharmaceutical packaging manufacturers?

The largest Italian pharmaceutical packaging machinery manufacturers are concentrated in the Bologna area. Marchesini Group (EUR 500M+ revenue, 87% exports), IMA Group (EUR 1.5B+ revenue, 84% exports), Romaco (Italian operations in Bologna), and CAM are among the most prominent. Dozens of smaller specialized firms round out the cluster, covering everything from capsule filling to labeling and serialization.

How large is Italy’s pharmaceutical packaging machinery sector?

Italy’s total packaging machinery sector reached EUR 10.2 billion in turnover in 2025, with exports of EUR 8.1 billion. The pharmaceutical segment is one of the strongest verticals, driven by biologics demand, serialization mandates, and Italy’s position as the world’s third-largest exporter of packaged drugs.

What regulations drive demand for pharma packaging machinery?

The EU’s Falsified Medicines Directive (FMD) requires serialization with 2D DataMatrix codes on prescription medicines. The US Drug Supply Chain Security Act (DSCSA) imposes similar requirements. Countries across Asia, Latin America, and the Middle East are adopting comparable mandates. Each new regulation creates demand for upgraded packaging lines with integrated track-and-trace capability.

Can AI outbound work for complex pharma packaging machinery sales?

AI outbound is effective for opening conversations about complex capital equipment purchases. No one buys a EUR 800,000 blister line from an email. But procurement and packaging directors respond to well-researched outreach that references their specific product types, regulatory environment, and expansion plans. The goal is to start qualified technical conversations, not close deals via email.

How does AI outbound compare to attending Pharmintech or CPhI?

AI outbound complements fairs rather than replacing them. Pharmintech and CPhI are useful for live demonstrations and relationship building. But they offer only 15 to 20 selling days per year. AI outbound runs 365 days, reaching 500 to 1,000 targeted prospects per month at $150 to $300 per qualified lead, compared to $300 to $900+ at fairs. The combination of both channels creates a pipeline that never goes dark.

---

Italian pharmaceutical packaging manufacturers build the machines that keep the global drug supply safe, traceable, and compliant. The companies that pair that engineering excellence with modern, scalable sales infrastructure will capture the growing global demand. Learn how AI-powered outbound works or explore how it applies to your specific markets and product lines.